Glenview Trust CO Bristol Myers Squibb CO Transaction History

Glenview Trust CO

  • $5.68 Billion
  • Q2 2025

A detailed history of Glenview Trust CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Glenview Trust CO holds 105,606 shares of BMY stock, worth $4.7 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
105,606
Previous 106,425 0.77%
Holding current value
$4.7 Million
Previous $6.49 Million 24.68%
% of portfolio
0.09%
Previous 0.13%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$44.12 - $59.6 $36,134 - $48,812
-819 Reduced 0.77%
105,606 $4.89 Million
Q1 2025

May 20, 2025
SELL
$53.9 - $63.11 $19,134 - $22,404
-355 Reduced 0.33%
106,425 $6.49 Million
Q4 2024

Feb 10, 2025
BUY
$51.92 - $59.94 $220,608 - $254,685
4,249 Added 4.14%
106,780 $6.04 Million
Q3 2024

Nov 12, 2024
BUY
$39.66 - $51.75 $38,589 - $50,352
973 Added 0.96%
102,531 $5.31 Million
Q2 2024

Aug 14, 2024
BUY
$40.25 - $52.99 $57,114 - $75,192
1,419 Added 1.42%
101,558 $4.22 Million
Q1 2024

May 14, 2024
BUY
$47.98 - $54.4 $27,972 - $31,715
583 Added 0.59%
100,139 $5.43 Million
Q4 2023

Feb 12, 2024
SELL
$48.48 - $57.85 $501,186 - $598,053
-10,338 Reduced 9.41%
99,556 $5.11 Million
Q3 2023

Nov 13, 2023
BUY
$57.89 - $64.73 $25,876 - $28,934
447 Added 0.41%
109,894 $6.38 Million
Q2 2023

Aug 14, 2023
BUY
$63.71 - $70.74 $68,934 - $76,540
1,082 Added 1.0%
109,447 $7 Million
Q1 2023

May 09, 2023
SELL
$65.71 - $74.53 $32,197 - $36,519
-490 Reduced 0.45%
108,365 $7.51 Million
Q4 2022

Feb 08, 2023
BUY
$68.48 - $81.09 $152,025 - $180,019
2,220 Added 2.08%
108,855 $7.83 Million
Q3 2022

Nov 04, 2022
SELL
$0.13 - $76.84 $30 - $17,980
-234 Reduced 0.22%
106,635 $7.58 Million
Q2 2022

Aug 10, 2022
BUY
$72.62 - $79.98 $80,608 - $88,777
1,110 Added 1.05%
106,869 $8.23 Million
Q1 2022

May 11, 2022
SELL
$61.48 - $73.72 $42,851 - $51,382
-697 Reduced 0.65%
105,759 $7.72 Million
Q4 2021

Feb 10, 2022
SELL
$53.63 - $62.52 $218,756 - $255,019
-4,079 Reduced 3.69%
106,456 $6.64 Million
Q3 2021

Nov 12, 2021
SELL
$59.17 - $69.31 $2,425 - $2,841
-41 Reduced 0.04%
110,535 $6.54 Million
Q2 2021

Aug 11, 2021
SELL
$61.91 - $67.42 $172,357 - $187,697
-2,784 Reduced 2.46%
110,576 $7.39 Million
Q1 2021

May 12, 2021
SELL
$59.34 - $66.74 $147,044 - $165,381
-2,478 Reduced 2.14%
113,360 $7.16 Million
Q4 2020

Feb 02, 2021
SELL
$57.74 - $65.43 $90,825 - $102,921
-1,573 Reduced 1.34%
115,838 $7.19 Million
Q3 2020

Nov 12, 2020
SELL
$57.43 - $63.64 $107,566 - $119,197
-1,873 Reduced 1.57%
117,411 $7.08 Million
Q2 2020

Aug 12, 2020
SELL
$54.82 - $64.09 $99,827 - $116,707
-1,821 Reduced 1.5%
119,284 $7.01 Million
Q1 2020

Apr 28, 2020
SELL
$46.4 - $67.43 $187,688 - $272,754
-4,045 Reduced 3.23%
121,105 $6.75 Million
Q4 2019

Feb 06, 2020
BUY
$49.21 - $64.19 $1.46 Million - $1.9 Million
29,573 Added 30.94%
125,150 $8.03 Million
Q3 2019

Nov 14, 2019
SELL
$42.77 - $50.71 $35,328 - $41,886
-826 Reduced 0.86%
95,577 $4.85 Million
Q2 2019

Aug 08, 2019
SELL
$44.62 - $49.34 $87,142 - $96,361
-1,953 Reduced 1.99%
96,403 $0
Q1 2019

May 14, 2019
SELL
$45.12 - $53.8 $65,965 - $78,655
-1,462 Reduced 1.46%
98,356 $4.69 Million
Q4 2018

Feb 14, 2019
BUY
$48.76 - $63.23 $19,699 - $25,544
404 Added 0.41%
99,818 $5.19 Million
Q3 2018

Nov 14, 2018
BUY
$55.19 - $62.25 $10,817 - $12,201
196 Added 0.2%
99,414 $6.17 Million
Q2 2018

Aug 10, 2018
SELL
$50.53 - $62.98 $117,532 - $146,491
-2,326 Reduced 2.29%
99,218 $5.49 Million
Q1 2018

May 14, 2018
SELL
$59.92 - $68.98 $121,038 - $139,339
-2,020 Reduced 1.95%
101,544 $0
Q4 2017

Feb 06, 2018
SELL
$59.94 - $65.35 $14,385 - $15,683
-240 Reduced 0.23%
103,564 $6.35 Million
Q3 2017

Nov 07, 2017
BUY
$55.23 - $63.74 $5.73 Million - $6.62 Million
103,804
103,804 $6.62 Million

Others Institutions Holding BMY

# of Institutions
2,660
Shares Held
1.64B
Call Options Held
22.4M
Put Options Held
25.4M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $94.7B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Glenview Trust CO Portfolio

Follow Glenview Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Glenview Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email